1. Home
  2. KREF vs ORGO Comparison

KREF vs ORGO Comparison

Compare KREF & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KKR Real Estate Finance Trust Inc.

KREF

KKR Real Estate Finance Trust Inc.

N/A

Current Price

$8.44

Market Cap

623.9M

Sector

Real Estate

ML Signal

N/A

Logo Organogenesis Holdings Inc.

ORGO

Organogenesis Holdings Inc.

N/A

Current Price

$4.93

Market Cap

539.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KREF
ORGO
Founded
2014
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
623.9M
539.1M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
KREF
ORGO
Price
$8.44
$4.93
Analyst Decision
Buy
Buy
Analyst Count
6
3
Target Price
$10.71
$8.00
AVG Volume (30 Days)
843.1K
3.1M
Earning Date
10-21-2025
11-06-2025
Dividend Yield
11.79%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$62,012,000.00
$465,218,000.00
Revenue This Year
$16.86
$8.14
Revenue Next Year
N/A
$6.33
P/E Ratio
N/A
N/A
Revenue Growth
N/A
2.24
52 Week Low
$7.78
$2.61
52 Week High
$11.74
$7.08

Technical Indicators

Market Signals
Indicator
KREF
ORGO
Relative Strength Index (RSI) 53.59 46.12
Support Level $8.38 $4.87
Resistance Level $8.63 $5.83
Average True Range (ATR) 0.17 0.34
MACD 0.04 -0.12
Stochastic Oscillator 70.34 3.38

Price Performance

Historical Comparison
KREF
ORGO

About KREF KKR Real Estate Finance Trust Inc.

KKR Real Estate Finance Trust Inc is a real estate finance company that focuses on originating and acquiring senior mortgage loans secured by CRE assets. The investment is to originate or acquire senior mortgage loans collateralized by institutional-quality CRE assets that are owned and operated by experienced and well-capitalized sponsors and located in liquid markets with underlying fundamentals. KKR manages investments across multiple asset classes, including private equity, real estates, energy, infrastructure, credit, and hedge funds. The company's investment objective is capital preservation and generating attractive risk-adjusted returns for its stockholders over the long term, through dividends.

About ORGO Organogenesis Holdings Inc.

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.

Share on Social Networks: